FDA cleared the VERITON CT 300 Series Digital SPECT/CT System (VERITON CT 316/364); VERITON CT 400 Series Digital SPECT/CT System (VERITON CT 416/464) from Spectrum Dynamics Medical, Ltd. on Jan 13, 2026 under K254001, a special 510(k). The device falls under product code KPS, System, Tomography, Computed, Emission, regulated at 21 CFR 892.1200 as a Class 2 device. The review panel was Radiology.
FDA logged the submission as received on Dec 15, 2025. The decision came 29 days later, inside the 90 FDA-day goal for a 510(k).
Spectrum Dynamics Medical, Ltd. has one other decision in the tracker over the last 12 months: K253532 (TruSPECT Processing Station).
Questions & Answers
What did FDA clear under K254001?
K254001 is the FDA 510(k) for VERITON CT 300 Series Digital SPECT/CT System (VERITON CT 316/364); VERITON CT 400 Series Digital SPECT/CT System (VERITON CT 416/464), submitted by Spectrum Dynamics Medical, Ltd.. FDA's decision date was Jan 13, 2026, under product code KPS (System, Tomography, Computed, Emission).
Who makes the VERITON CT 300 Series Digital SPECT/CT System (VERITON CT 316/364); VERITON CT 400 Series Digital SPECT/CT System (VERITON CT 416/464)?
Spectrum Dynamics Medical, Ltd., based in Caesarea, is the applicant of record for K254001.
How long did the K254001 review take?
FDA received the submission on Dec 15, 2025 and issued its decision on Jan 13, 2026, 29 days later.